Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 18 Mar 2025

Multimodal diagnostic models and subtype analysis for neoadjuvant therapy in breast cancer

in Cancer Immunity and Immunotherapy

Zheng Ye
Jiaqi Yuan
Deqing Hong
Peng Xu
Wenbin Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1559200

1,240 views

Original Research

Published on 18 Mar 2025

Revealing gut microbiota biomarkers associated with melanoma immunotherapy response and key bacteria-fungi interaction relationships: evidence from metagenomics, machine learning, and SHAP methodology

in Cancer Immunity and Immunotherapy

Yuhang Zhou
Wenjie Han
Yun Feng
Yue Wang
Xiaolin Liu
Tao Sun
Junnan Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1539653

1,028 views

Original Research

Published on 18 Mar 2025

Enhancing pancreatic cancer treatment: the role of H101 oncolytic virus in irreversible electroporation

in Cancer Immunity and Immunotherapy

Pu Xi
Dejun Zeng
Miao Chen
Lingmin Jiang
Yu Zhang
Dailei Qin
Zehui Yao
Chaobin He

Frontiers in Immunology

doi 10.3389/fimmu.2025.1546242

950 views
1 citation

Review

Published on 18 Mar 2025

Exploring the roles of ncRNAs in prostate cancer via the PI3K/AKT/mTOR signaling pathway

in Cancer Immunity and Immunotherapy

Rongwang Guo
Liji Shi
Yonghui Chen
Canling Lin
Weihua Yin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1525741

777 views

Original Research

Published on 18 Mar 2025

Molecular characteristics and cancer immunity of LRP1B and its relationship with the Hedgehog signaling pathway in colorectal cancer

in Cancer Immunity and Immunotherapy

Yuan Liu
Yang Zhong
Yaodong Sang
Siqiang Zhu
Kang Xu
Xingyu Zhu
Xiaoling Cui
Xinyu Liu
Xiaohan Wang
Hao Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1567102

761 views

Original Research

Published on 18 Mar 2025

Identification of prognostic subtypes and the role of FXYD6 in ovarian cancer through multi-omics clustering

in Cancer Immunity and Immunotherapy

Boyi Ma
Chenlu Ren
Yun Gong
Jia Xi
Yuan Shi
Shuhua Zhao
Yadong Yin
Hong Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1556715

652 views

Original Research

Published on 18 Mar 2025

A high content clonogenic survival drug screening identifies maytansine as a potent radiosensitizer for meningiomas

in Cancer Immunity and Immunotherapy

Jinxiu Yu
Jiaojiao Deng
Leihao Ren
Lingyang Hua
Tianqi Wu
Yi Hui
Chunlin Shao
Ye Gong

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557165

599 views

Review

Published on 18 Mar 2025

Unveiling the immunological landscape: comprehensive characterization of neoantigen-reactive immune cells in neoantigen cancer vaccines

in Cancer Immunity and Immunotherapy

Weijiang Liu
Hong Su
Peng Guo
Liping Hong
Xishan Hao
Xiaoling Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1537947

553 views

Systematic Review

Published on 18 Mar 2025

Limitations of nomogram models in predicting survival outcomes for glioma patients

in Cancer Immunity and Immunotherapy

Jihao Xue
Hang Liu
Lu Jiang
Qijia Yin
Ligang Chen
Ming Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1547506

647 views

Editorial

Published on 18 Mar 2025

Editorial: Vector-based gene delivery in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Ning Cheng
Xiaoyue Yang
Dan Chen
Chun Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1587359

416 views

Mini Review

Published on 18 Mar 2025

Emerging immunotherapies in osteosarcoma: from checkpoint blockade to cellular therapies

in Cancer Immunity and Immunotherapy

Zhiwei Han
Guomin Chen
Dongchen Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1579822

723 views

Review

Accepted on 17 Mar 2025

Deep Learning for Malignant Lymph Node Segmentation and Detection: A Review

in Cancer Immunity and Immunotherapy

Wenxia Wu
Adrien Laville
Eric Deutsch
Roger Sun

Frontiers in Immunology

doi 10.3389/fimmu.2025.1526518

191 views

Original Research

Accepted on 17 Mar 2025

Moderate toxicity with late onset as a good omen: association between toxicity and survival in the checkpoint inhibitor immunotherapy -a single center experience

in Cancer Immunity and Immunotherapy

Anna Rudzińska
Pola Juchaniuk
Jakub Oberda
Kamila Krukowska
Sylwia Krzyśkowska
Eliza Kuchta
Anna Rodzajewska
Mariola Janiszewska
Katarzyna Szklener
Katarzyna Machulska-Ciuraj

Frontiers in Immunology

doi 10.3389/fimmu.2025.1527103

Case Report

Published on 17 Mar 2025

Case Report: Pembrolizumab in a patient with preexisting paraneoplastic dermatomyositis and sarcomatoid urothelial carcinoma. Searching for balance

in Cancer Immunity and Immunotherapy

Mariangela Torniai
Giuseppe Pio Martino
Calogero Gucciardino
Stefano Angelici
Renato Bisonni

Frontiers in Immunology

doi 10.3389/fimmu.2025.1558964

912 views

Mini Review

Published on 17 Mar 2025

New progress in imaging diagnosis and immunotherapy of breast cancer

in Cancer Immunity and Immunotherapy

Jie He
Nan Liu
Li Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1560257

1,066 views

Brief Research Report

Published on 17 Mar 2025

High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment

in Cancer Immunity and Immunotherapy

Briana Amicarella Burns
Manasvi Chandra
Vanaja Konduri
William K. Decker

Frontiers in Immunology

doi 10.3389/fimmu.2025.1522755

878 views